CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ASCLEPIUS project aims to enhance research on phage therapy for bacterial infections. By fostering collaboration between institutions, it seeks to improve knowledge transfer and support early-stage researchers in this field.
ASCLEPIUS’s overall aim is to boost the scientific excellence and innovation capacity of Giorgi Eliava Institute of Bacteriophagy, Microbiology and Virology (Eliava) and its high-quality Twinning partners - l’Institut national de recherche pour l’agriculture, l’alimentation et l’environnement, Universidade do Minho and Intelligentsia Consultants Sarl – to expand their insights in phage therapy for treating Pseudomonas aeruginosa and Staphylococcus aureus.
To achieve this aim, ASCLEPIUS will impl…
GIORGI ELIAVA INSTITUTE OF BACTERIOPHAGY, MICROBIOLOGY AND VIROLOGY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Portugal, Braga
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Luxembourg, Bertrange
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
